CAR With Half Of CTLA-4

CAR with Half of CTLA-4
Recently, some researchers have combined CCT with CAR-C-terminal to construct three CARs targeting CD22: CAR-1CCT, CAR-2CCT, and CAR-3CCT, which also improved tumor therapeutic efficacy after gaining endocytosis.